Federation des caisses Desjardins du Quebec
Position in SCLX — Scilex Holding Co
CIK 2022297
LEVIS, A8
Position in SCLX
as of Mar 31, 2026
· filed May 14, 2026
Position Value
$13
-$11 QoQ
Shares Held
2
0.0% QoQ
Ownership
0.000%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Jun 2025
4 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in SCLX Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Mar 31, 2026Federation des caisses Desjardins du Quebec holds $574,805,026 across 19 Drug Manufacturers - General names. SCLX ranks #19 (0.0% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | JNJ |
Johnson & Johnson
|
683,670 | $167,116,292 | |
| 2 | LLY |
ELI LILLY & Co
|
109,969 | $101,146,185 | |
| 3 | PFE |
Pfizer Inc
|
2,480,449 | $69,651,005 | |
| 4 | MRK |
Merck & Co., Inc.
|
570,879 | $68,671,033 | |
| 5 | ABBV |
AbbVie Inc.
|
205,779 | $44,754,872 | |
| 6 | AZN |
Astrazeneca PLC
|
168,010 | $33,134,932 | |
| 7 | GILD |
Gilead Sciences, Inc.
|
189,702 | $26,438,765 | |
| 8 | SNY |
Sanofi
|
403,774 | $19,453,830 |
All Filings in SCLX
Export CSV
4 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $13 | 2 | Shares | Defined | 2026-05-14 | |
| 2025-12-31 | $24 | 2 | Shares | Defined | 2026-02-12 | |
| 2025-09-30 | $59 | 3 | Shares | Defined | 2025-11-14 | |
| 2025-06-30 | $17 | 3 | Shares | Defined | 2025-08-14 | |
| No filing history on record for this holder in this stock. | ||||||